ac immune initiates final cohort in ongoing phase 1b2 abate trial of anti abeta active immunotherapy to treat alzheimers disease

EPU_POLICY_REGULATORYGENERAL_HEALTHTAX_DISEASE_DISEASEWB_1406_DISEASES

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.